Review
Version 1
Preserved in Portico This version is not peer-reviewed
Cutting-Edge Diagnostic Tools for Cardiac Amyloidosis Detection
Version 1
: Received: 5 July 2024 / Approved: 5 July 2024 / Online: 5 July 2024 (07:28:40 CEST)
How to cite: Bashir, Z.; Khan, B.; Bukhari, S. Cutting-Edge Diagnostic Tools for Cardiac Amyloidosis Detection. Preprints 2024, 2024070498. https://doi.org/10.20944/preprints202407.0498.v1 Bashir, Z.; Khan, B.; Bukhari, S. Cutting-Edge Diagnostic Tools for Cardiac Amyloidosis Detection. Preprints 2024, 2024070498. https://doi.org/10.20944/preprints202407.0498.v1
Abstract
The prevalence of cardiac amyloidosis (CA), especially as a cause of heart failure, has significantly increased in recent years. Early detection and accurate assessment of the disease burden are crucial for initiating timely treatment and ensuring precise prognosis. CA primarily results from the infiltration of the myocardium by either immunoglobulin light chain fibrils (AL) or transthyretin fibrils (ATTR), leading to restrictive cardiomyopathy and eventual death if untreated.
Over the past decade, advancements in diagnostic imaging and heightened clinical awareness have revealed a substantial presence of CA, particularly ATTR, among the elderly. These diagnostic improvements encompass echocardiography, cardiac computerized tomography scan, magnetic resonance imaging, and radionuclide scintigraphy with bone-avid tracers. Concurrently, significant progress has been made in therapeutic options, with new disease-modifying treatments now available that can dramatically alter the disease trajectory and improve survival rates when administered early. However, despite these advancements, there remains an urgent need for the early and accurate detection of CA to ensure that patients can fully benefit from these emerging therapies.
Keywords
cardiac amyloidosis; cardiac magnetic resonance; echocardiography; nuclear scintigraphy
Subject
Medicine and Pharmacology, Clinical Medicine
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment